These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12096038)

  • 21. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands.
    Zheng H; Heiderscheidt CA; Joo M; Gao X; Knezevic N; Mehta D; Sadikot RT
    Eur J Immunol; 2010 Jan; 40(1):162-71. PubMed ID: 19904768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibrio cholerae porin OmpU induces LPS tolerance by attenuating TLR-mediated signaling.
    Sakharwade SC; Mukhopadhaya A
    Mol Immunol; 2015 Dec; 68(2 Pt A):312-24. PubMed ID: 26454478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
    Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
    J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
    Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
    Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.
    Raschi E; Testoni C; Bosisio D; Borghi MO; Koike T; Mantovani A; Meroni PL
    Blood; 2003 May; 101(9):3495-500. PubMed ID: 12531807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A universal role for MyD88 in TLR/IL-1R-mediated signaling.
    Janssens S; Beyaert R
    Trends Biochem Sci; 2002 Sep; 27(9):474-82. PubMed ID: 12217523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
    Kadoki M; Choi BI; Iwakura Y
    Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MyD88-dependent induction of allergic Th2 responses to intranasal antigen.
    Piggott DA; Eisenbarth SC; Xu L; Constant SL; Huleatt JW; Herrick CA; Bottomly K
    J Clin Invest; 2005 Feb; 115(2):459-67. PubMed ID: 15650773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212.
    Nahid MA; Yao B; Dominguez-Gutierrez PR; Kesavalu L; Satoh M; Chan EK
    J Immunol; 2013 Feb; 190(3):1250-63. PubMed ID: 23264652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance.
    Dalpke AH; Lehner MD; Hartung T; Heeg K
    Immunology; 2005 Oct; 116(2):203-12. PubMed ID: 16162269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase.
    Jacinto R; Hartung T; McCall C; Li L
    J Immunol; 2002 Jun; 168(12):6136-41. PubMed ID: 12055225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells.
    Gon Y; Nunomura S; Ra C
    Clin Exp Allergy; 2005 May; 35(5):635-42. PubMed ID: 15898987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Toll-like receptors and MyD88 in innate immune responses.
    Akira S; Hoshino K; Kaisho T
    J Endotoxin Res; 2000; 6(5):383-7. PubMed ID: 11521059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD14 is required for MyD88-independent LPS signaling.
    Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Huber M; Kalis C; Keck S; Galanos C; Freudenberg M; Beutler B
    Nat Immunol; 2005 Jun; 6(6):565-70. PubMed ID: 15895089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
    Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.